2-37645984-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006449.5(CDC42EP3):c.604G>A(p.Glu202Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000283 in 1,613,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006449.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDC42EP3 | NM_006449.5 | c.604G>A | p.Glu202Lys | missense_variant | 2/2 | ENST00000295324.4 | NP_006440.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDC42EP3 | ENST00000295324.4 | c.604G>A | p.Glu202Lys | missense_variant | 2/2 | 1 | NM_006449.5 | ENSP00000295324 | P1 | |
ENST00000702971.1 | n.105-15631C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000187 AC: 47AN: 250914Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135582
GnomAD4 exome AF: 0.000289 AC: 422AN: 1461680Hom.: 0 Cov.: 32 AF XY: 0.000283 AC XY: 206AN XY: 727144
GnomAD4 genome AF: 0.000224 AC: 34AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.000256 AC XY: 19AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2024 | The c.604G>A (p.E202K) alteration is located in exon 2 (coding exon 1) of the CDC42EP3 gene. This alteration results from a G to A substitution at nucleotide position 604, causing the glutamic acid (E) at amino acid position 202 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at